Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2019046903) A THERAPEUTIC METHOD OF INCREASING MUSCLE MASS IN A SUBJECT
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2019/046903 International Application No.: PCT/AU2018/050973
Publication Date: 14.03.2019 International Filing Date: 07.09.2018
IPC:
A61K 38/17 (2006.01) ,A61K 48/00 (2006.01) ,A61P 21/06 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38
Medicinal preparations containing peptides
16
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
17
from animals; from humans
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
48
Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
21
Drugs for disorders of the muscular or neuromuscular system
06
Anabolic agents
Applicants:
BAKER HEART AND DIABETES INSTITUTE [AU/AU]; 75 Commercial Road Melbourne, Victoria 3004, AU
Inventors:
GREGOREVIC, Paul; AU
DAVEY, Jonathan, Robert, Geoffrey; AU
Agent:
FB RICE PTY LTD; Level 14, 90 Collins St Melbourne, Victoria 3000, AU
Priority Data:
201790365008.09.2017AU
Title (EN) A THERAPEUTIC METHOD OF INCREASING MUSCLE MASS IN A SUBJECT
(FR) PROCÉDÉ THÉRAPEUTIQUE POUR AUGMENTER LA MASSE MUSCULAIRE CHEZ UN SUJET
Abstract:
(EN) The present disclosure provides a method of increasing muscle mass in a subject, the method comprising administering to the subject follistatin or a functional fragment thereof for a period of time and in an amount sufficient to effect an increase in muscle mass, wherein the administration increases the level of a follistatin protein in the subject compared to a control level, and wherein the increased level of the protein is normalised before the onset of the increase in muscle mass.
(FR) La présente invention concerne un procédé pour augmenter la masse musculaire chez un sujet, le procédé comprenant l'administration, au sujet, de follistatine ou d'un fragment fonctionnel correspondant pendant une période de temps et en une quantité suffisante pour effectuer une augmentation de la masse musculaire, l'administration augmentant le taux d'une protéine follistatine chez le sujet par rapport à un niveau témoin et le niveau augmenté de la protéine étant normalisé avant l'apparition de l'augmentation de la masse musculaire.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)